Remgro Ltd (STU:RE7)
€ 7.25 -0.15 (-2.03%) Market Cap: 4.21 Bil Enterprise Value: 4.30 Bil PE Ratio: 25.39 PB Ratio: 0.73 GF Score: 66/100

Full Year 2023 Remgro Ltd Earnings Call Transcript

Sep 21, 2023 / 07:00AM GMT
Release Date Price: €7.55 (+0.67%)
Operator

Good day, ladies and gentlemen, and welcome to the Remgro Limited annual results. (Operator Instructions) Please note that this call is being recorded. I would now like to turn the conference over to Jannie Durand, CEO. Please go ahead.

Jan Jonathan Durand
Remgro Limited - Chairman of Management Board, CEO & Executive Director

Good morning, everybody, and welcome to the annual results presentation of Remgro Limited for the year ended 30 June 2023. Just to run you through the contents of the day, I will start by giving a performance overview. We will rate ourselves against our strategic priorities. And then I'll also briefly discuss the operating context of the environment that we've been operating during the past 12 months. Then I will hand over to Neville to give a more detailed overview of our results for the year. And then we deviated a little bit from our usual format in previous years. We will then begin an update on some of our key investments. And I welcome Ronnie van der Merwe and Jurgens Myburgh, the CEO and CFO, respectively, of Mediclinic, who

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot